Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy

Background: Invasive and non-invasive pneumococcal diseases are significant health and economic burdens, especially in children and the elderly. Italy included the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccine (PCV13) in the National Immunization Program in 2007 and 2010, respectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansaldi, Filippo, Pugh, Sarah, Amicizia, Daniela, Di Virgilio, Roberto, Trucchi, Cecilia, Orsi, Andrea, Zollo, Alessandro, Icardi, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168640/
https://www.ncbi.nlm.nih.gov/pubmed/31979079
http://dx.doi.org/10.3390/pathogens9020076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168640/
https://www.ncbi.nlm.nih.gov/pubmed/31979079
http://dx.doi.org/10.3390/pathogens9020076

Ejemplares similares